Amyloid β-Protein Fibrillogenesis

Cited by (1,000)

Items 201–300 of 1,000

1. Capturing Intermediate Structures of Alzheimer's β-Amyloid, Aβ(1−40), by Solid-State NMR Spectroscopy
   Sandra Chimon, Yoshitaka Ishii · 2005 · Journal of the American Chemical Society
2. Acceleration of Amyloid β-Peptide Aggregation by Physiological Concentrations of Calcium
   Adrian M. Isaacs, David B. Senn, Menglan Yuan, James P. Shine, Bruce A. Yankner · 2006 · Journal of Biological Chemistry
3. Chemical, Thermal, and Electric Field Induced Unfolding of Single Protein Molecules Studied Using Nanopores
   Kevin J. Freedman, Maike C. Jürgens, Anmiv S. Prabhu, Chi Won Ahn, Per Jemth, Joshua B. Edel, Min Jun Kim · 2011 · Analytical Chemistry
4. New Class of Inhibitors of Amyloid-β Fibril Formation
   Hilal Ahmed Lashuel, Dean M. Hartley, David Balakhaneh, Aneel K. Aggarwal, Saul Teichberg, David J.E. Callaway · 2002 · Journal of Biological Chemistry
5. Self-assembly of ionic-complementary peptides: a physicochemical viewpoint
   P. Chen · 2005 · Colloids and Surfaces A Physicochemical and Engineering Aspects
6. Fine structure study of Aβ 1–42 fibrillogenesis with atomic force microscopy
   Muriel Arimon, Ismael Díez‐Pérez, Marcelo Javier Kogan, Núria Durany, Ernest Giralt, Fausto Sanz, Xavier Fernàndez‐Busquets · 2005 · The FASEB Journal
7. Evidence for a Mechanism of Amyloid Formation Involving Molecular Reorganisation within Native-like Precursor Aggregates
   Georgia Plakoutsi, Francesco Bemporad, Martino Calamai, Niccolò Taddei, Christopher Martin Dobson, Fabrizio Chiti · 2005 · Journal of Molecular Biology
8. Glial cell dysregulation: a new perspective on Alzheimer disease
   Rommy von Bernhardi M. · 2007 · Neurotoxicity Research
9. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease
   Akihiko Nunomura, Shigeru Chiba, Carol Frances Lippa, Patrick P Cras, Raj N. Kalaria, Atsushi Takeda, Kazuhiro Honda, Mark A. Smith, George L. Perry · 2004 · Neurobiology of Disease
10. Structure and function of amyloid in Alzheimer's disease
    Carlos Morgan, Marcela Colombres, Marco Tulio Núñez, Nibaldo C. Inestrosa · 2004 · Progress in Neurobiology
11. 1α,25-Dihydroxyvitamin D3 and Resolvin D1 Retune the Balance between Amyloid-β Phagocytosis and Inflammation in Alzheimer's Disease Patients
    Mathew T. Mizwicki, Guanghao Liu, Milan Fiala, Larry I. Magpantay, James William Sayre, Avi Siani, Michelle Mahanian, Rachel E. Weitzman, Eric Y. Hayden, Mark J. Rosenthal et al. · 2013 · Journal of Alzheimer s Disease
12. NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106–126
    Kazuo Kuwata, Tomoharu Matumoto, Hong Cheng, Kuniaki Nagayama, Thomas Leroy James, Heinrich Röder · 2003 · Proceedings of the National Academy of Sciences
13. Oligomerization of Amyloid Aβ16–22 Peptides Using Hydrogen Bonds and Hydrophobicity Forces
    Giorgio Favrin, Anders Irbäck, Sandipan Mohanty · 2004 · Biophysical Journal
14. LRP in Amyloid‐β Production and Metabolism
    Guojun Bu, Judy A. Cam, Celina Zerbinatti · 2006 · Annals of the New York Academy of Sciences
15. Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597–624)
    Shaked, G. M., Kummer, M. P., Lu, D. C., Galvan, V., Bredesen, D. E., Koo, E. H., Shaked, G. M., Kummer, M. P., Lu, D. C., Galvan, V. et al. · 2006 · The FASEB Journal
16. Structural properties of Aβ protofibrils stabilized by a small molecule
    Angela D. Williams, Matt Sega, Maolian Chen, Indu Kheterpal, Merav Geva, Valérie Berthelier, David T. Kaleta, Kelsey D. Cook, Ronald B. Wetzel · 2005 · Proceedings of the National Academy of Sciences
17. Pathways and Intermediates of Amyloid Fibril Formation
    Riccardo Pellarin, Enrico Guarnera, Amedeo Caflisch · 2007 · Journal of Molecular Biology
18. β-Secretase-Cleaved Amyloid Precursor Protein Accumulates at Actin Inclusions Induced in Neurons by Stress or Amyloid β: A Feedforward Mechanism for Alzheimer's Disease
    Michael T. Maloney, Laurie S. Minamide, Andrew W. Kinley, Judith A. Boyle, James R. Bamburg · 2005 · Journal of Neuroscience
19. Oxidation of Methionine 35 Attenuates Formation of Amyloid β-Peptide 1–40 Oligomers
    Magnus Palmblad, Anita Westlind‐Danielsson, Jonas Bergquist · 2002 · Journal of Biological Chemistry
20. Pathway Complexity of Alzheimer's β-Amyloid Aβ16-22 Peptide Assembly
    Sébastien Santini, Guanghong Wei, Normand Mousseau, Philippe Derreumaux · 2004 · Structure
21. Conserved features of intermediates in amyloid assembly determine their benign or toxic states
    Rajaraman Krishnan, Jessica L. Goodman, Samrat Mukhopadhyay, Chris D. Pacheco, Edward A. Lemke, Ashok A. Deniz, Susan Lee Lindquist · 2012 · Proceedings of the National Academy of Sciences
22. Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases
    Dillon J. Rinauro, Fabrizio Chiti, Michele Vendruscolo, Ryan Limbocker · 2024 · Molecular Neurodegeneration
23. Glycosaminoglycans and β-amyloid, prion and tau peptides in neurodegenerative diseases
    Javier Díaz‐Nido, Francisco G. Wandosell, Jesús Ávila · 2002 · Peptides
24. Behavioral Assessment of Alzheimer's Transgenic Mice Following Long-Term A β Vaccination: Task Specificity and Correlations between A β Deposition and Spatial Memory
    Gary W. Arendash, Marcia N. Gordon, David M. Diamond, Leigh Ann Austin, Jaime M. Hatcher-Martin, Paul T. Jantzen, Giovanni DiCarlo, Donna M. Wilcock, David Morgan · 2001 · DNA and Cell Biology
25. Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4
    Sı́lvia Casas, Anna Novials, Frank M. Reimann, Ramón Gomis, Fiona Mary Gribble · 2008 · Diabetologia
26. Switchable photooxygenation catalysts that sense higher-order amyloid structures
    Atsuhiko Taniguchi, Yusuke Shimizu, Kounosuke Oisaki, Youhei Sohma, Motomu Kanai · 2016 · Nature Chemistry
27. Characterization of Chemical Exchange between Soluble and Aggregated States of β-Amyloid by Solution-State NMR upon Variation of Salt Conditions
    Saravanakumar Narayanan, Bernd Reif · 2005 · Biochemistry
28. Amyloid-β fibrillogenesis: Structural insight and therapeutic intervention
    Kevin Da Silva, James Edward Shaw, JoAnne McLaurin · 2009 · Experimental Neurology
29. Fibril Elongation by Aβ17–42: Kinetic Network Analysis of Hybrid-Resolution Molecular Dynamics Simulations
    Wei Han, Klaus J. Schulten · 2014 · Journal of the American Chemical Society
30. Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides
    Caroline Grönwall, Andreas Jonsson, Sara Lindström, Elin Gunneriusson, Stefan Ståhl, Nina Herne · 2006 · Journal of Biotechnology
31. Alzheimer’s amyloid β-peptide (1–42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide
    David Allan Butterfield, Ashley Ian Bush · 2004 · Neurobiology of Aging
32. Small heat shock protein HspB8: its distribution in Alzheimer’s disease brains and its inhibition of amyloid-β protein aggregation and cerebrovascular amyloid-β toxicity
    Micha M.M. Wilhelmus, Wilbert C. Boelens, Irene Otte‐Höller, Bram Kamps, Benno Küsters, Marion L. C. Maat–Schieman, Robert M.W. de Waal, Marcel M. Verbeek · 2006 · Acta Neuropathologica
33. Protein misfolding in neurodegenerative diseases
    Eleftherios I. Agorogiannis, G. I. Agorogiannis, Alexandros Papadimitriou, George M. Hadjigeorgiou · 2004 · Neuropathology and Applied Neurobiology
34. Self-Assembly of Short Aβ(16−22) Peptides: Effect of Terminal Capping and the Role of Electrostatic Interaction
    Kai Tao, Jiqian Wang, Peng Zhou, Chengdong Wang, Hai Xu, Xiubo Zhao, Jian Ren Lu · 2011 · Langmuir
35. Control of peptide conformation by the Thorpe-Ingold effect (C?-tetrasubstitution)
    Claudio Toniolo, Marco Crisma, Fernando Formaggio, Cristina Peggion · 2001 · Biopolymers
36. Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment
    Eugenio Barone, Fabio Di Domenico, Rukhsana Sultana A, Raffaella Coccia, Cesare Mancuso, Marzia Perluigi A, David Allan Butterfield · 2012 · Free Radical Biology and Medicine
37. A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils.
    Youcef Fezoui, David B. Teplow, Dean M. Hartley, Dominic M. Walsh, Dennis J. Selkoe, John J. Osterhout · 2000 · Nature Structural Biology
38. Inflammatory mechanisms in neurodegeneration
    Michael R. Nichols, Marie‐Kim St‐Pierre, Ann‐Christin Wendeln, Nyasha J. Makoni, Lisa K. Gouwens, Evan C. Garrad, Mona Sohrabi, Jonas J. Neher, Marie‐Ève Tremblay, Colin Kelly Combs · 2019 · Journal of Neurochemistry
39. Aβ Protofibrils Possess a Stable Core Structure Resistant to Hydrogen Exchange
    Indu Kheterpal, Hilal Ahmed Lashuel, Dean M. Hartley, Thomas Walz, Peter T. Lansbury, Ronald B. Wetzel · 2003 · Biochemistry
40. Alzheimer’s β-peptide oligomer formation at physiologic concentrations
    Harry LeVine · 2004 · Analytical Biochemistry
41. Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-β Accumulation
    Nathalie Pierrot, Susana Ferrão Santos, Christine Feyt, Marina Morel, Jean‐Pierre Brion, Jean Noël Octave · 2006 · Journal of Biological Chemistry
42. High molecular weight amyloid β 1‐42 oligomers induce neurotoxicity via plasma membrane damage
    Taro Yasumoto, Yusaku Takamura, Mayumi Tsuji, Takahiro Watanabe‐Nakayama, Keiko Imamura, Haruhisa Inoue, Shiro Nakamura, Tomio Inoue, Atsushi Kimura, Satoshi Yano et al. · 2019 · The FASEB Journal
43. Alzheimer's Disease and the Amyloid β-Protein
    Dominic M. Walsh, David B. Teplow · 2012 · Progress in molecular biology and translational science
44. APP/Aβ structural diversity and Alzheimer's disease pathogenesis
    Alex E. Roher, Tyler A. Kokjohn, Steven Gerard Clarke, Michael R. Sierks, Chera L. Maarouf, Geidy E. Serrano, Marwan Sabbagh, Thomas G. Beach · 2017 · Neurochemistry International
45. Kinetic characterization of amyloid-beta 1–42 aggregation with a multimethodological approach
    Manuela Bartolini, Marina Naldi, Jessica Fiori, Francesco Valle, Fabio Biscarini, Dan Veniamin Nicolau, Vincenza Andrisano · 2011 · Analytical Biochemistry
46. Single-Particle Characterization of Aβ Oligomers in Solution
    Erik C. Yusko, Panchika Prangkio, David Sept, Ryan C. Rollings, Jiali Li, Michael Mayer · 2012 · ACS Nano
47. Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation
    Francis T. Hane, Zoya Leonenko · 2014 · Biomolecules
48. Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer’s Disease: Insights from Meta-Analyses
    Liang Shen, Hong‐Fang Ji · 2015 · Journal of Alzheimer s Disease
49. The various aggregation states of β-amyloid 1–42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression
    Elena Tamagno, Paola Bardini, Michela Guglielmotto, Oliviero Danni, Massimo Tabaton · 2006 · Free Radical Biology and Medicine
50. Protein aggregation, metals and oxidative stress in neurodegenerative diseases
    B.J. Tabner, O.M.A. El-Agnaf, Matthew J. German, Nigel J. Fullwood, David Allsop · 2005 · Biochemical Society Transactions
51. The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity
    Cristina Cecchi, Massimo Stefani · 2013 · Biophysical Chemistry
52. Protofibril Formation of Amyloid β-Protein at Low pH via a Non-cooperative Elongation Mechanism
    Rita Carrotta, Mauro Manno, Donatella Bulone, Vincenzo Martorana, Pier Luigi San Biagio · 2005 · Journal of Biological Chemistry
53. Aggregation Pathways of the Amyloid β(1–42) Peptide Depend on Its Colloidal Stability and Ordered β-Sheet Stacking
    Dianlu Jiang, Iris E. Rauda, Shubo Han, Shu Chen, Feimeng Zhou · 2012 · Langmuir
54. Conversion of non-fibrillar β-sheet oligomers into amyloid fibrils in Alzheimer’s disease amyloid peptide aggregation
    Núria Benseny‐Cases, M. Cócera, Josep Cladera · 2007 · Biochemical and Biophysical Research Communications
55. Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases
    Gianluigi Forloni, Vladimiro Artuso, Pietro La Vitola, Claudia Balducci · 2016 · Movement Disorders
56. In vitro studies of amyloid β-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692→Gly) Alzheimer's disease
    Dominic M. Walsh, Dean M. Hartley, Margaret M. Condron, Dennis J. Selkoe, David B. Teplow · 2001 · Biochemical Journal
57. Amyloid Cross-Seeding: Mechanism, Implication, and Inhibition
    Sushma Subedi, Santanu Sasidharan, Niharika Nag, Prakash Saudagar, Timir Tripathi · 2022 · Molecules
58. Examining the zinc binding site of the amyloid‐β peptide
    Dun‐Sheng Yang, JoAnne McLaurin, Kefeng Qin, David A. Westaway, Paul E. Fraser · 2000 · European Journal of Biochemistry
59. Amyloid-β Protofibrils Differ from Amyloid-β Aggregates Induced in Dilute Hexafluoroisopropanol in Stability and Morphology
    Michael R. Nichols, Melissa A. Moss, Dana Kim Reed, Stephanie Cratic-McDaniel, Jan H. Hoh, Terrone L. Rosenberry · 2004 · Journal of Biological Chemistry
60. Single Chain Variable Fragments against β-Amyloid (Aβ) Can Inhibit Aβ Aggregation and Prevent Aβ-Induced Neurotoxicity
    Ruitian Liu, Bin Yuan, Sharareh Emadi, Andleeb Zameer, Philip Schulz, Chad McAllister, Yuri L. Lyubchenko, Gaddam Narsa Goud, Michael R. Sierks · 2004 · Biochemistry
61. Two Distinct Amyloid β-Protein (Aβ) Assembly Pathways Leading to Oligomers and Fibrils Identified by Combined Fluorescence Correlation Spectroscopy, Morphology, and Toxicity Analyses
    Satoko Matsumura, Keiko Shinoda, Mayumi Yamada, Satoshi Yokojima, Masafumi Inoue, Takayuki Ohnishi, Tetsuya Shimada, Kazuya Kikuchi, Dai Masui, Shigeki Hashimoto et al. · 2011 · Journal of Biological Chemistry
62. Unraveling the Early Events of Amyloid-β Protein (Aβ) Aggregation: Techniques for the Determination of Aβ Aggregate Size
    N. Elizabeth Pryor, Melissa A. Moss, Christa N. Hestekin · 2012 · International Journal of Molecular Sciences
63. Inhibitors of Catalase-Amyloid Interactions Protect Cells from β-Amyloid-Induced Oxidative Stress and Toxicity
    Lila K. Habib, Michelle T.C. Lee, Jerry Yang · 2010 · Journal of Biological Chemistry
64. Physiochemical characterization of the Alzheimer's disease‐related peptides Aβ1–42Arctic and Aβ1–42wt
    Ann‐Sofi Johansson, Fredrik Berglind‐Dehlin, Göran Karlsson, Katarina Edwards, Pär Gellerfors, Lars Lannfelt · 2006 · FEBS Journal
65. Amyloid Fibril-Like Structure Underlies the Aggregate Structure across the pH Range for β-Lactoglobulin
    Mark R.H. Krebs, Glyn L. Devlin, Athene M. Donald · 2009 · Biophysical Journal
66. The Alzheimer's Amyloid-β(1–42) Peptide Forms Off-Pathway Oligomers and Fibrils That Are Distinguished Structurally by Intermolecular Organization
    William M. Tay, Danting Huang, Terrone L. Rosenberry, Anant K. Paravastu · 2013 · Journal of Molecular Biology
67. Reversible Random Coil to β-Sheet Transition and the Early Stage of Aggregation of the Aβ(12−28) Fragment from the Alzheimer Peptide
    Jüri Jarvet, Peter Damberg, Karl Bodell, L. E. Göran Eriksson, Astrid Gräslund · 2000 · Journal of the American Chemical Society
68. Synaptic Dysfunction in Alzheimer’s Disease
    Elena E. Marcello, Roberta Epis, Claudia Saraceno, Mónica Di Luca · 2012 · Advances in experimental medicine and biology
69. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment
    Rukhsana Sultana A, David Allan Butterfield · 2009 · Journal of Bioenergetics and Biomembranes
70. The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain
    Silvia Fossati, Patrizia Giannoni, María E. Solesio, Sarah L. Cocklin, Erwin Cabrera, Jorge A. Ghiso, Agueda A. Rostagno · 2015 · Neurobiology of Disease
71. β‐Amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH
    Genevieve M Klug, Dušan Lošić, Supundi, Supundi Subasinghe, Marie‐Isabel Aguilar, Lisandra L. Martin, David Henry Small · 2003 · European Journal of Biochemistry
72. Analysis of Protein Aggregation in Neurodegenerative Disease
    Jeppe T. Pedersen, Niels H. H. Heegaard · 2013 · Analytical Chemistry
73. c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo
    Alessandra Sclip, Alessandro Tozzi, Aziza Abaza, Daniele Cardinetti, Isabella Colombo, Paolo Calabresi, Mario Salmona, Egbert Welker, Tiziana Borsello · 2014 · Cell Death and Disease
74. Adsorption of Amyloid β (1–40) Peptide at Phospholipid Monolayers
    Elena Maltseva, Andreas Kerth, Alfred Blume, Helmuth Möhwald, Gerald Brezesinski · 2005 · ChemBioChem
75. Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease
    Butterfield, D. Allan, Boyd‐Kimball, Debra · 2019 · Journal of Neurochemistry
76. The Tottori (D7N) and English (H6R) Familial Alzheimer Disease Mutations Accelerate Aβ Fibril Formation without Increasing Protofibril Formation
    Yukiko Hori, Tadafumi Hashimoto, Yosuke Wakutani, Katsuya Urakami, Kenji Nakashima, Margaret M. Condron, Satoshi Tsubuki, Takaomi C. Saido, David B. Teplow, Takeshi Iwatsubo · 2006 · Journal of Biological Chemistry
77. Amyloidogenesis of Type III-dependent Harpins from Plant Pathogenic Bacteria
    Jonghee Oh, Jung‐Gun Kim, Eunkyung Jeon, Chang-Hyuk Yoo, Jae Sun Moon, Sangkee Rhee, Ingyu Hwang · 2007 · Journal of Biological Chemistry
78. Protein Aggregation and Amyloid Fibril Formation by an SH3 Domain Probed by Limited Proteolysis
    Patrizia Polverino de Laureto, Niccolò Taddei, Erica Frare, Cristina Capanni, Silvia Costantini, Jesús Zurdo, Fabrizio Chiti, Christopher Martin Dobson, Angelo Fontana · 2003 · Journal of Molecular Biology
79. Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain
    Kristina Magnusson, Dag Sehlin, Stina Syvänen, Marie M. Svedberg, Ola Philipson, Linda Söderberg, Karin Tegerstedt, Mats Holmquist, Pär Gellerfors, Толмачев Владимир Максимилианович et al. · 2013 · Journal of Alzheimer s Disease
80. Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation
    Massimo Stefani, Stefania Rigacci · 2014 · BioFactors
81. Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Aβ fibril formation pathway
    Sungmun Lee, Erik Fernández, Theresa A. Good · 2007 · Protein Science
82. Small Molecule Oxidation Products Trigger Disease-Associated Protein Misfolding
    Jan Bieschke, Qinghai Zhang, Daryl A. Bosco, Richard Alan Lerner, Evan T. Powers, Paul Wentworth, Jeffery W. Kelly · 2006 · Accounts of Chemical Research
83. Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins
    Marcos Jair Guerrero‐Munoz, Diana Laura Castillo‐Carranza, Rakez Kayed · 2014 · Biochemical Pharmacology
84. Probing the Initial Stage of Aggregation of the Aβ10-35-protein: Assessing the Propensity for Peptide Dimerization
    Bogdan Tarus, John E. Straub, Dave Thirumalai · 2004 · Journal of Molecular Biology
85. Selective destabilization of soluble amyloid β oligomers by divalent metal ions
    Garai, K., Sengupta, P., Sahoo, B., Maiti, S. · 2006 · Biochemical and Biophysical Research Communications
86. Alternate Aggregation Pathways of the Alzheimer β-Amyloid Peptide: Aβ Association Kinetics at Endosomal pH
    Paul M. Gorman, Christopher M. Yip, Paul E. Fraser, Avijit Chakrabartty · 2002 · Journal of Molecular Biology
87. A nontransgenic mouse model shows inducible amyloid-β (Aβ) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade
    Dolev, Iftach, Michaelson, Daniel M. · 2004 · Proceedings of the National Academy of Sciences
88. Cholinergic neuropathology in a mouse model of Alzheimer's disease
    Dwight C. German, Umar Yazdani, Samuel G. Speciale, Parichehr Pasbakhsh, Dora Games, Chang‐Lin Liang · 2003 · The Journal of Comparative Neurology
89. Biflavonoids Are Superior to Monoflavonoids in Inhibiting Amyloid-β Toxicity and Fibrillogenesis via Accumulation of Nontoxic Oligomer-like Structures
    Arjun Thapa, Eun‐Rhan Woo, Eva Y. Chi, Md Golam Sharoar, Hong-Guang Jin, Song Yub Shin, Il‐Seon Park · 2011 · Biochemistry
90. Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
    Jens Moreth, Chrystelle Mavoungou, Katharina Schindowski · 2013 · Immunity & Ageing
91. Solution structure of eggcase silk protein and its implications for silk fiber formation
    Zhi Lin, Weidong Huang, Jingfeng Zhang, Jing‐Song Fan, Daiwen Yang · 2009 · Proceedings of the National Academy of Sciences
92. Amyloid‐β oligomers are inefficiently measured by enzyme‐linked immunosorbent assay
    Stenh, Charlotte, Englund, Hillevi, Lord, Anna, Johansson, Ann‐Sofi, Almeida, Claudia G., Gellerfors, Pär, Greengard, Paul, Gouras, Gunnar K., Lannfelt, Lars, Nilsson, Lars N. G. · 2005 · Annals of Neurology
93. Protofibrils, the unifying toxic molecule of neurodegenerative disorders?
    Christian Haass, Harald Steiner · 2001 · Nature Neuroscience
94. An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies
    Deborah A. Ryan, Wade C. Narrow, Howard J. Federoff, William J. Bowers · 2010 · Journal of Neuroscience Methods
95. Glutamate and Amyloid β-Protein Rapidly Inhibit Fast Axonal Transport in Cultured Rat Hippocampal Neurons by Different Mechanisms
    Hiromi Hiruma, Takashi Katakura, Sanae Takahashi, Takafumi Ichikawa, Tadashi Kawakami · 2003 · Journal of Neuroscience
96. Galantamine inhibits β-amyloid aggregation and cytotoxicity
    Balpreet Matharu, Gillian L. Gibson, Richard B. Parsons, Thomas N. Huckerby, Susan A. Moore, Leanne J. Cooper, Robert Millichamp, David Allsop, Brian Austen · 2009 · Journal of the Neurological Sciences
97. Structures of β-Amyloid Peptide 1−40, 1−42, and 1−55—the 672−726 Fragment of APP—in a Membrane Environment with Implications for Interactions with γ-Secretase
    Naoyuki Miyashita, John E. Straub, Dave Thirumalai · 2009 · Journal of the American Chemical Society
98. The amyloid‐β peptide and its role in Alzheimer's disease
    Andrew B. Clippingdale, John D. Wade, Colin James Barrow · 2001 · Journal of Peptide Science
99. Mechanisms of amyloid plaque pathogenesis
    John C. Fiala · 2007 · Acta Neuropathologica
100. Impact of the Mutation A21G (Flemish Variant) on Alzheimer’s β-Amyloid Dimers by Molecular Dynamics Simulations
     Alexis Huet, Philippe Derreumaux · 2006 · Biophysical Journal